China pharmaceutical and biotechnology month (annual subscription )—- Aarkstore Market Research Company aggregation
China Pharmaceutical & Biotechnology Monthly is the intelligent guide to the healthcare industry in China. Filled with news, analysis, and coverage of financial markets, CPB Monthly is essential for professionals and managers serious about tracking the opportunities and challenges presented by China. Content includes top stories, figures and key events, general news, politics and regulations, investment and finance, business, trade, research and development and intellectual property law. It also has two company profiles and capital market.
What I get with a subscription?
• You receive a monthly newsletter PDF file with all the news of the month, articles from lead, and the capital markets view
• You get access to summaries of Daily news headlines and complete articles, as they believe in www.gbipharma.com
• You receive a weekly email that includes headlines and links Articles that
• You have access to any podcasts or interviews conducted GB
Table of Contents:
Major articles on topics current
Interviews with industry leaders
Key facts and figures
Daily news clips covering:
• Policies and regulations
• Investment and finance
• multinational and Chinese companies updates
• Research and Development
• IP & Legal
• Hospitals
Great deals
Company Earnings
Profiles of academic and industry
Leaders
Profiles of new and established
Chinese enterprises
Research Highlights
Equity Markets Review
Events
For more information, please visit:
http://www.aarkstore.com/reports/China-Pharmaceutical-Biotechnology-Monthly-Annual-Subscription–2003.html
Or e-mail or call +919272852585 press@aarkstore.com
Welcome To My Biotech Channel!
|
|
Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials $121.38 “The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies.” —From the Afterword by Anthony D. Dayan Proper preclinic… |
|
|
Models of the Visual System (TOPICS IN BIOMEDICAL ENGINEERING $125.09 Over the past thirty years, with improvements in optics, electronics, and computer technology, great strides have been made in the quantitative analysis of the visual system. A number of books on eye movement research have been written that have dealt with specific aspects of either eye movement control. However, none of these books provide a comprehensive overview of multiple aspects of the … |
|
|
Failure of Apoptosis and Cancer Metastasis (Biotechnology Intelligence Unit) $139.00 This book summarizes recent reports on adhesion-dependent regulation of apoptosis. The author discusses data indicating that highly metastatic cancer cells exhibit a superior survival ability and resistance to apoptosis induced by diverse external signals. He also shows that increased survival of metastatic cancer cells compared to nonmetastatic or poorly metastatic cells is associated with their … |